Latest filing published 07 Jan 2022 for ACACIA PHARMA GROUP, €6,427.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Brown John in Acacia Pharma Group. We count 3 filings; the first trade dates from 30 June 2021 and the latest from 29 December 2021.
The open-market record is one-sided, with 3 purchases worth €19k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2022: 1 purchase and no sales on the market.
Half of the purchases are above €6,427 and half below. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The record was last updated on 7 January 2022 with an open-market purchase (€6,427) in Acacia Pharma Group. Typically, a trade is published a median of 12 days after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19). This summary is built from FSMA disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 2 declarations